In the Matter of Bodisen Biotech, Inc., China Global Media, Inc., China Heli Resource Renewable, Inc., and GFR Pharmaceuticals, Inc.; Order of Suspension of Trading, 32820-32821 [2016-12288]
Download as PDF
<![CDATA[
sradovich on DSK3TPTVN1PROD with NOTICES
32820
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
questions with user-friendly response
features such as radio buttons, dropdown menu responses, pop-up
explanation bubbles, Web page links,
fillable narrative text fields, and
document upload options. In addition,
the OMMS Form incorporates
functionality that, depending upon
certain responses, pre-populates specific
fields, and prompts the user to provide
additional information. By eliciting
specific information from the user, the
OMMS Form will facilitate
communication between the user and
the Ombudsman, reduce response and
resolution times, and maximize
Ombudsman staff resources available for
recording, processing, and responding
to matters. The requested information
collection is voluntary and will not
change the contact methods currently
available.
The Commission expects that OMMS
will be operative and the OMMS Form
publicly available through the
Commission’s Web site, https://
www.sec.gov.
The Commission estimates that the
total reporting burden for using the
OMMS Form will be 250 hours. The
calculation of this estimate depends on
how many members of the public use
the form each year and the estimated
time it takes to complete the forms: 500
respondents × 30 minutes per
submission = 250 burden hours. The
estimates of average burden hours are
made solely for the purposes of the
Paperwork Reduction Act. The total
estimated one-time cost to the federal
government of creating OMMS and the
OMMS Form is $400,000.
An agency may not conduct or
sponsor a collection of information
unless it displays a currently valid
control number. No person shall be
subject to any penalty for failing to
comply with a collection of information
subject to the PRA that does not display
a valid Office of Management and
Budget control number.
Written comments are invited on all
aspects of this proposed information
collection request, in particular: (a)
Whether this collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information will have
practical utility; (b) the accuracy of the
agency’s estimate of the burden imposed
by the collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information collected; and
(d) ways to minimize the burden of the
collection of information on users,
including through the use of automated
collection techniques or other forms of
information technology.
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
Consideration will be given to
comments and suggestions submitted in
writing within 60 days of this
publication. Please direct your written
comments to Pamela Dyson, Director/
Chief Information Officer, Securities
and Exchange Commission, c/o Remi
Pavlik-Simon, 100 F Street NE.,
Washington, DC 20549; or send an email
to: PRA_Mailbox@sec.gov.
SECURITIES AND EXCHANGE
COMMISSION
Dated: May 18, 2016.
Robert W. Errett,
Deputy Secretary.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Bodisen
Biotech, Inc. (CIK No. 1178552), a
forfeited Delaware corporation with its
principal place of business listed as
Shaanxi, China with stock quoted on
OTC Link (previously, ‘‘Pink Sheets’’)
operated by OTC Markets Group, Inc.
(‘‘OTC Link’’) under the ticker symbol
BBCZ, because it has not filed any
periodic reports since the period ended
June 30, 2013. On August 18, 2015, a
delinquency letter was sent by the
Division of Corporation Finance to
Bodisen Biotech, Inc. requesting
compliance with its periodic filing
obligations, but Bodisen Biotech, Inc.
refused to accept delivery of the
delinquency letter.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of China
Global Media, Inc. (CIK No. 1450015), a
revoked Nevada corporation with its
principal place of business listed as
Hunan Province, China with stock
quoted on OTC Link under the ticker
symbol CGLO, because it has not filed
any periodic reports since the period
ended June 30, 2013. On August 18,
2015, a delinquency letter was sent by
the Division of Corporation Finance to
China Global Media, Inc. requesting
compliance with its periodic filing
obligations, and China Global Media,
Inc. did not receive the delinquency
letter due to its failure to maintain a
valid address on file with the
Commission as required by Commission
rules (Rule 301 of Regulation S–T, 17
CFR 232.301 and Section 5.4 of EDGAR
Filer Manual).
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of China Heli
Resource Renewable, Inc. (CIK No.
1081823), a British Virgin Islands
corporation with its principal place of
business listed as Xin Jiang Province,
China with stock quoted on OTC Link
under the ticker symbol CRRWF,
because it has not filed any periodic
reports since the period ended
[FR Doc. 2016–12116 Filed 5–23–16; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
In the Matter of NuTech Energy
Resources, Inc.; Order of Suspension
of Trading
May 20, 2016.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of NuTech
Energy Resources, Inc. (‘‘NERG’’)
because of concerns regarding the
accuracy and adequacy of information
in the marketplace about the company’s
operations and the company’s recent
public announcements concerning an
unsolicited tender offer. NERG is a
Delaware corporation with its principal
place of business located in Gillette,
Wyoming. Its stock is quoted on OTC
Link, operated by OTC Markets Group
Inc., under the ticker: NERG.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
company.
Therefore, it is ordered, pursuant to
Section 12(k) of the Securities Exchange
Act of 1934, that trading in the
securities of the above-listed company is
suspended for the period from 9:30 a.m.
EDT on May 20, 2016, through 11:59
p.m. EDT on June 3, 2016.
By the Commission.
Lynn M. Powalski,
Deputy Secretary.
[FR Doc. 2016–12290 Filed 5–20–16; 11:15 am]
BILLING CODE 8011–01–P
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
[File No. 500–1]
In the Matter of Bodisen Biotech, Inc.,
China Global Media, Inc., China Heli
Resource Renewable, Inc., and GFR
Pharmaceuticals, Inc.; Order of
Suspension of Trading
May 20, 2016.
E:\FR\FM\24MYN1.SGM
24MYN1
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
December 31, 2012. On August 18, 2015,
a delinquency letter was sent by the
Division of Corporation Finance to
China Heli Resource Renewable, Inc.
requesting compliance with its periodic
filing obligations, but China Heli
Resource Renewable, Inc. did not
receive the delinquency letter due to its
failure to maintain a valid address on
file with the Commission as required by
Commission rules (Rule 301 of
Regulation S–T, 17 CFR 232.301 and
Section 5.4 of EDGAR Filer Manual).
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of GFR
Pharmaceuticals, Inc. (CIK No.
1096294), a Nevada corporation with its
principal place of business listed as
Shaanxi Province, China with stock
quoted on OTC Link under the ticker
symbol GFRP, because it has not filed
any periodic reports since the period
ended March 31, 2013. On November 3,
2015, a delinquency letter was sent by
the Division of Corporation Finance to
GFR Pharmaceuticals, Inc. requesting
compliance with its periodic filing
obligations, and GFR Pharmaceuticals,
Inc. received the delinquency letter on
November 9, 2015, but failed to cure its
delinquencies.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
companies.
Therefore, it is ordered, pursuant to
Section 12(k) of the Securities Exchange
Act of 1934, that trading in the
securities of the above-listed companies
is suspended for the period from 9:30
a.m. EDT on May 20, 2016, through
11:59 p.m. EDT on June 3, 2016.
By the Commission.
Brent J. Fields,
Secretary.
[FR Doc. 2016–12288 Filed 5–20–16; 11:15 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
sradovich on DSK3TPTVN1PROD with NOTICES
Submission for OMB Review;
Comment Request
Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of FOIA Services,
100 F Street NE., Washington, DC
20549–2736.
Extension: Rule 17Ad–17.
SEC File No. 270–412, OMB Control No.
3235–0469.
Notice is hereby given that pursuant
to the Paperwork Reduction Act of 1995
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
(‘‘PRA’’) (44 U.S.C. 3501 et seq.), the
Securities and Exchange Commission
(‘‘Commission’’) has submitted to the
Office of Management and Budget
(‘‘OMB’’) a request for approval of
extension of the previously approved
collection of information provided for in
Rule 17Ad–2(c), (d), and (h), (17 CFR
240.17Ad–2(c), (d), and (h)), under the
Securities Exchange Act of 1934 (15
U.S.C. 78a et seq.).
Rule 17Ad–17 requires transfer agents
and broker-dealers to make two searches
for the correct address of lost
securityholders using an information
database without charge to the lost
securityholders. In addition, paying
agents are required to attempt to notify
lost payees at least once. The
Commission staff estimates that the rule
applies to approximately 301 broker
dealers and 2,766 paying agent entities,
including carrying firms, transfer agents,
indenture trustees, custodians, and
approximately 10% of issuers. The
Commission staff estimates that the total
burden is 88,619 hours, representing the
hours associated with searches and
notifications. Approximately 2,686
hours are associated with
recordkeeping.
The retention period for the
recordkeeping requirement under Rule
17Ad–17 is not less than three years
following the date the notice is
submitted. The recordkeeping
requirement under this rule is
mandatory to assist the Commission in
monitoring compliance with the rule.
This rule does not involve the collection
of confidential information.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
under the PRA unless it displays a
currently valid OMB control number.
The public may view background
documentation for this information
collection at the following Web site:
www.reginfo.gov. Comments should be
directed to: (i) Desk Officer for the
Securities and Exchange Commission,
Office of Information and Regulatory
Affairs, Office of Management and
Budget, Room 10102, New Executive
Office Building, Washington, DC 20503,
or by sending an email to: Shagufta_
Ahmed@omb.eop.gov; and (ii) Pamela
Dyson, Director/Chief Information
Officer, Securities and Exchange
Commission, c/o Remi Pavlik-Simon,
100 F Street NE., Washington, DC
20549, or by sending an email to: PRA_
Mailbox@sec.gov. Comments must be
submitted to OMB within 30 days of
this notice.
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
32821
Dated: May 18, 2016.
Robert W. Errett,
Deputy Secretary.
[FR Doc. 2016–12115 Filed 5–23–16; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
Sunshine Act Meeting
Notice is hereby given, pursuant to
the provisions of the Government in the
Sunshine Act, Public Law 94–409, that
the Securities and Exchange
Commission will hold a Closed Meeting
on Thursday, May 26, 2016 at 2:00 p.m.
Commissioners, Counsel to the
Commissioners, the Secretary to the
Commission, and recording secretaries
will attend the Closed Meeting. Certain
staff members who have an interest in
the matters also may be present.
The General Counsel of the
Commission, or her designee, has
certified that, in her opinion, one or
more of the exemptions set forth in 5
U.S.C. 552b(c)(3), (5), (7), 9(B) and (10)
and 17 CFR 200.402(a)(3), (5), (7), 9(ii)
and (10), permit consideration of the
scheduled matter at the Closed Meeting.
Chair White, as duty officer, voted to
consider the items listed for the Closed
Meeting in closed session.
The subject matter of the Closed
Meeting will be:
Institution and settlement of injunctive
actions;
Institution and settlement of
administrative proceedings;
Adjudicatory matters; and
Other matters relating to enforcement
proceedings.
At times, changes in Commission
priorities require alterations in the
scheduling of meeting items.
For further information and to
ascertain what, if any, matters have been
added, deleted or postponed, please
contact Brent J. Fields from the Office of
the Secretary at (202) 551–5400.
Dated: May 19, 2016.
Brent J. Fields,
Secretary.
[FR Doc. 2016–12291 Filed 5–20–16; 11:15 am]
BILLING CODE 8011–01–P
DEPARTMENT OF STATE
[Public Notice: 9579]
60-Day Notice of Proposed Information
Collection: Application for A, G, or
NATO Visa
Notice of request for public
comment.
ACTION:
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Pages 32820-32821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12288]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[File No. 500-1]
In the Matter of Bodisen Biotech, Inc., China Global Media,
Inc., China Heli Resource Renewable, Inc., and GFR Pharmaceuticals,
Inc.; Order of Suspension of Trading
May 20, 2016.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Bodisen Biotech, Inc. (CIK No. 1178552), a forfeited Delaware
corporation with its principal place of business listed as Shaanxi,
China with stock quoted on OTC Link (previously, ``Pink Sheets'')
operated by OTC Markets Group, Inc. (``OTC Link'') under the ticker
symbol BBCZ, because it has not filed any periodic reports since the
period ended June 30, 2013. On August 18, 2015, a delinquency letter
was sent by the Division of Corporation Finance to Bodisen Biotech,
Inc. requesting compliance with its periodic filing obligations, but
Bodisen Biotech, Inc. refused to accept delivery of the delinquency
letter.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
China Global Media, Inc. (CIK No. 1450015), a revoked Nevada
corporation with its principal place of business listed as Hunan
Province, China with stock quoted on OTC Link under the ticker symbol
CGLO, because it has not filed any periodic reports since the period
ended June 30, 2013. On August 18, 2015, a delinquency letter was sent
by the Division of Corporation Finance to China Global Media, Inc.
requesting compliance with its periodic filing obligations, and China
Global Media, Inc. did not receive the delinquency letter due to its
failure to maintain a valid address on file with the Commission as
required by Commission rules (Rule 301 of Regulation S-T, 17 CFR
232.301 and Section 5.4 of EDGAR Filer Manual).
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
China Heli Resource Renewable, Inc. (CIK No. 1081823), a British Virgin
Islands corporation with its principal place of business listed as Xin
Jiang Province, China with stock quoted on OTC Link under the ticker
symbol CRRWF, because it has not filed any periodic reports since the
period ended
[[Page 32821]]
December 31, 2012. On August 18, 2015, a delinquency letter was sent by
the Division of Corporation Finance to China Heli Resource Renewable,
Inc. requesting compliance with its periodic filing obligations, but
China Heli Resource Renewable, Inc. did not receive the delinquency
letter due to its failure to maintain a valid address on file with the
Commission as required by Commission rules (Rule 301 of Regulation S-T,
17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual).
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
GFR Pharmaceuticals, Inc. (CIK No. 1096294), a Nevada corporation with
its principal place of business listed as Shaanxi Province, China with
stock quoted on OTC Link under the ticker symbol GFRP, because it has
not filed any periodic reports since the period ended March 31, 2013.
On November 3, 2015, a delinquency letter was sent by the Division of
Corporation Finance to GFR Pharmaceuticals, Inc. requesting compliance
with its periodic filing obligations, and GFR Pharmaceuticals, Inc.
received the delinquency letter on November 9, 2015, but failed to cure
its delinquencies.
The Commission is of the opinion that the public interest and the
protection of investors require a suspension of trading in the
securities of the above-listed companies.
Therefore, it is ordered, pursuant to Section 12(k) of the
Securities Exchange Act of 1934, that trading in the securities of the
above-listed companies is suspended for the period from 9:30 a.m. EDT
on May 20, 2016, through 11:59 p.m. EDT on June 3, 2016.
By the Commission.
Brent J. Fields,
Secretary.
[FR Doc. 2016-12288 Filed 5-20-16; 11:15 am]
BILLING CODE 8011-01-P
